Drug Trial Radar · NCT07623057
A Study Testing the Safety and Effects of FB102 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
64
Planned (sponsor's estimate)
Start
Jun 23, 2026
Primary completion
Feb 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Forte Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this Phase 1 trial is to evaluate the safety and effects of FB-102 in healthy volunteers following single and multiple doses.
Conditions
- Healthy Volunteer
Interventions
FB102 Single dose - Part ABiological
FB102 will be administered as a single dose
FB102 Multiple doses - Part BBiological
FB102 will be administered once weekly for 4 doses.
FB102 PlaceboDrug
Matching placebo identical to FB102 formulation but without the active pharmaceutical ingredient
FB102 Multiple doses - Part CBiological
FB102 will be administered once every 2 weeks for 4 doses.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence, severity, and relationship to treatment of treatment-emergent adverse events (TEAEs)Time frame: From day 1 to Day 85 (End of treatment visit)
- Incidence, severity, and relationship to treatment of SAEsTime frame: From day 1 to Day 85 (End of treatment visit)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Sunshine Coast, Morayfield
Eastwood, Queensland, Australia · Recruiting
University of Sunshine Coast Clinical Trials, Maroochydore
Maroochydore, Queensland, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.